Aravive Inc (ARAV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ARAV | MRNA | BMY | AMGN | GILD |
| Company | Aravive Inc | Moderna Inc | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 0.0435 | 105.14 | 48.44 | 267.54 | 67.35 |
| High | 0.0460 | 105.14 | 48.55 | 268.77 | 67.55 |
| Low | 0.0401 | 102.27 | 47.70 | 263.39 | 66.89 |
| Last | 0.0401 | 103.44 | 47.84 | 264.07 | 66.93 |
| Change | -0.0062 | -0.35 | -0.42 | -1.57 | -0.38 |
| % Change | -13.39% | -0.34% | -0.87% | -0.59% | -0.56% |
| Volume | 4,040,000 | 2,000,200 | 11,763,000 | 2,175,100 | 5,287,700 |
| 20-Day Average Volume | 3,905,935 | 3,324,430 | 11,395,495 | 2,225,995 | 6,258,365 |
| Previous Close | 0.0463 | 103.79 | 48.26 | 265.64 | 67.31 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.0945 | 105.51 | 51.17 | 273.48 | 70.61 |
| 20-Day Raw Stochastic | 0.11% | 34.09% | 2.07% | 2.72% | 0.54% |
| 20-Day Relative Strength | 26.22% | 50.46% | 34.65% | 37.63% | 29.70% |
| Weighted Alpha | -75.45 | -18.19 | -31.08 | +4.99 | -24.05 |
| Today's Opinion | 100% Sell | 72% Buy | 56% Sell | 56% Sell | 100% Sell |
| Previous Opinion | 100% Sell | 72% Buy | 56% Sell | 40% Sell | 100% Sell |
| Last Month's Opinion | 100% Sell | 40% Buy | 24% Sell | 8% Sell | 88% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -23.18% since 01/19/24 | -3.45% since 04/10/24 | -4.87% since 04/10/24 | -0.89% since 04/10/24 | -1.75% since 04/10/24 |
| Low | 0.0400 on 01/23/24 | 101.30 on 04/16/24 | 47.70 on 04/17/24 | 263.39 on 04/17/24 | 66.89 on 04/17/24 |
| High | 0.0530 on 01/22/24 | 108.60 on 04/11/24 | 50.58 on 04/11/24 | 273.00 on 04/11/24 | 69.03 on 04/11/24 |
| 1-Month | |||||
| %Chg | -68.75% since 12/26/23 | -0.39% since 03/15/24 | -8.60% since 03/15/24 | -1.79% since 03/15/24 | -9.17% since 03/15/24 |
| Low | 0.0400 on 01/23/24 | 97.00 on 04/03/24 | 47.70 on 04/17/24 | 263.39 on 04/17/24 | 66.89 on 04/17/24 |
| High | 0.1292 on 01/02/24 | 115.89 on 04/09/24 | 54.47 on 03/28/24 | 288.57 on 03/28/24 | 74.28 on 03/21/24 |
| 3-Month | |||||
| %Chg | -70.73% since 10/26/23 | +3.08% since 01/17/24 | -4.28% since 01/17/24 | -13.16% since 01/17/24 | -22.61% since 01/17/24 |
| Low | 0.0400 on 01/23/24 | 84.06 on 02/13/24 | 47.58 on 02/06/24 | 263.39 on 04/17/24 | 66.89 on 04/17/24 |
| High | 0.1820 on 11/30/23 | 115.89 on 04/09/24 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 |
| 6-Month | |||||
| %Chg | -97.18% since 07/26/23 | +19.82% since 10/17/23 | -16.61% since 10/17/23 | -7.15% since 10/17/23 | -16.84% since 10/17/23 |
| Low | 0.0400 on 01/23/24 | 62.55 on 11/02/23 | 47.58 on 02/06/24 | 249.70 on 10/31/23 | 66.89 on 04/17/24 |
| High | 1.5050 on 07/31/23 | 115.97 on 01/08/24 | 57.59 on 10/18/23 | 329.72 on 02/05/24 | 87.86 on 01/19/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,950 | 39,739,116 | 97,811,392 | 142,361,536 | 83,806,128 |
| Shares Outstanding, K | 73,563 | 382,880 | 2,026,759 | 535,919 | 1,245,077 |
| Annual Sales | 9,140,000 | 6,848,000,000 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 |
| Annual Net Income | -76,320,000 | -4,714,000,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 |
| Last Quarter Sales | 2,760,000 | 2,811,000,000 | 11,477,000,000 | 8,196,000,000 | 7,114,000,000 |
| Last Quarter Net Income | 21,230,000 | 217,000,000 | 1,762,000,000 | 767,000,000 | 1,429,000,000 |
| 60-Month Beta | 2.19 | 1.62 | 0.39 | 0.58 | 0.19 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.10 on 11/09/23 | 0.55 on 02/22/24 | 1.70 on 02/02/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 |
| Latest Earnings Date | 05/08/24 | 05/02/24 | 04/25/24 | 05/02/24 | 04/25/24 |
| Most Recent Dividend | N/A | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | 0.770 on 03/14/24 |
| Next Ex-Dividends Date | N/A | N/A | 04/04/24 | 05/16/24 | 03/14/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 6.47 | 14.24 | 10.08 |